Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic therapy for hepatocellular carcinoma.

T W Leung1, P J Johnson

  • 1Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong.

Seminars in Oncology
|October 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mental health and employment outcomes in working-age US adults, 2010-2019.

Occupational medicine (Oxford, England)·2024
Same author

Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study.

The British journal of surgery·2021
Same author

Effects of publication bias on conservation planning.

Conservation biology : the journal of the Society for Conservation Biology·2019
Same author

Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2019
Same author

Pharmacokinetics of intravenous lithium chloride and assessment of agreement between two methods of lithium concentration measurement in the horse.

Equine veterinary journal·2017
Same author

Electronic Prompts Can Reduce The Number Of Unnecessary Clotting Screens Ordered For Patients.

Acute medicine·2017

Hepatocellular carcinoma (HCC) treatment is challenging. Recent advances in combination chemotherapy offer new hope for patients with advanced liver cancer, potentially making tumors resectable and improving outcomes.

Area of Science:

  • Hepatology
  • Medical Oncology
  • Cancer Research

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent global cancer.
  • Many patients are diagnosed with unresectable disease, leading to poor prognoses.
  • Current locoregional and intra-arterial treatments are limited to specific patient groups.

Purpose of the Study:

  • To review the current status of systemic therapy for Hepatocellular Carcinoma (HCC).
  • To explore recent advancements and the reconsideration of systemic treatment approaches for HCC.

Main Methods:

  • Review of recent literature on systemic chemotherapy for HCC.
  • Analysis of treatment outcomes and response rates.

Main Results:

Related Experiment Videos

  • Historically, single-agent chemotherapy showed limited success in HCC.
  • Emerging evidence suggests combination chemotherapy can induce resectability and complete pathologic responses.
  • Systemic therapy is the primary option for patients with advanced or metastatic HCC.

    • Conclusions:

    • Combination chemotherapy represents a significant shift in HCC treatment paradigms.
    • Further investigation into systemic therapy is warranted for advanced Hepatocellular Carcinoma.
    • Recent advancements offer improved therapeutic options for previously untreatable HCC patients.